Results 291 to 300 of about 192,321 (311)

Biological basis of sex differences in drug abuse: preclinical and clinical studies

Psychopharmacology, 2002
Wendy Lynch, Megan E Roth, Carroll Marilyn E   +2 more
exaly  

Prediction of antibiotic resistance: time for a new preclinical paradigm?

Nature Reviews Microbiology, 2017
Dan Andersson, Christian Munck, Morten Otto Alexander Sommer   +2 more
exaly  

Preclinical evaluation on anticancer drug: Endocrine therapy drug

Annual Meeting of the Japanese Society of Toxicology, 2007
openaire   +1 more source

Orthotopic models of cancer for preclinical drug evaluation

European Journal of Cancer, 2004
openaire   +1 more source

Modeling risk factors for nicotine and other drug abuse in the preclinical laboratory

Drug and Alcohol Dependence, 2009
Justin Anker, Jennifer L Perry
exaly  

Non-vascular drug eluting stents as localized controlled drug delivery platform: Preclinical and clinical experience

Journal of Controlled Release, 2013
Sanjay Garg, Namita Roy Choudhury, Ganessan Kichenadasse   +2 more
exaly  

Preclinical evaluation of anti-CD269 antibody–drug conjugates

European Journal of Cancer, 2016
A. Palfi, M. Kulke, C. Mueller, C. Lutz, A. Pahl, T. Hechler   +5 more
openaire   +1 more source

Advances in the preclinical testing of cancer therapeutic hypotheses

Nature Reviews Drug Discovery, 2011
William Sellers, Sellers William R, Caponigro Giordano   +2 more
exaly  

Preclinical evaluation of flesinoxan as a potential anxiolytic and antidepressant drug

European Journal of Pharmacology, 1990
J. Schipper, M. Tulp, H. Sybesma, F. Krijzer, J. Mos, J. vd Heyden, B. Olivier   +6 more
openaire   +1 more source

Drug-eluting stent safety: findings from preclinical studies

Expert Review of Cardiovascular Therapy, 2008
Aloke Finn, , Leslie Coleman
exaly